Lung Cancer Diagnosis System Based on Volatile Organic Compounds (VOCs) Profile Measured in Exhaled Breath
Source abstract
Abstract
Lung cancer is one of the world’s lethal diseases and detecting it at an early stage is crucial and difficult. This paper proposes a computer-aided lung cancer diagnosis system using volatile organic compounds (VOCs) data. A silicon microreactor, which consists of thousands of micropillars coated with an ammonium aminooxy salt, is used to capture the volatile organic compounds (VOCs) in the patients’ exhaled breath by means of oximation reactions. The proposed system ranks the features using the Pearson correlation coefficient and maximum relevance–minimum redundancy (mRMR) techniques. The selected features are fed to nine different classifiers to determine if the lung nodule is malignant or benign. The system is validated using a locally acquired dataset that has 504 patients’ data. The dataset is balanced and has 27 features of volatile organic compounds (VOCs). Multiple experiments were completed, and the best accuracy result is 87%, which was achieved using random forest (RF) either by using all 27 features without selection or by using the first 17 features obtained using maximum relevance–minimum redundancy (mRMR) while using an 80–20 train-test split. The correlation coefficient, maximum relevance–minimum redundancy (mRMR), and random forest (RF) importance agreed that C4H8O (2-Butanone) ranks as the best feature. Using only C4H8O (2-Butanone) for training, the accuracy results using the support vector machine, logistic regression, bagging and neural network classifiers are 86%, which approaches the best result. This shows the potential for these volatile organic compounds (VOCs) to serve as a significant screening tests for the diagnosis of lung cancer.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced Chemical Sensor Technologies · Olfactory and Sensory Function Studies · Insect Pheromone Research and Control
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
BioImaging Laboratory, Department of Bioengineering, University of Louisville, Louisville, KY 40292, USA
Department of Chemical Engineering, University of Louisville, Louisville, KY 40292, USA
Department of Chemistry, University of Louisville, Louisville, KY 40292, USA
Department of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, KY 40292, USA
Funding
U.S. Department of Defense
References (42)
Show source-provided references
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries10.3322/caac.21660 ↗
2. Early diagnosis of lung cancer10.12703/P5-12 ↗
3. Cancer statistics, 201810.3322/caac.21654 ↗
4. Gordienko, Y., Gang, P., Hui, J., Zeng, W., Kochura, Y., Alienin, O., Rokovyi, O., and Stirenko, S. (2018, January 18–20). Deep learning with lung segmentation and bone shadow exclusion techniques for chest X-ray analysis of lung cancer. Proceedings of the International Conference on Computer Science, Engineering and Education Applications, Kiev, Ukraine.10.1007/978-3-319-91008-6_63 ↗
5. Classification of lung cancer subtypes based on autofluorescence bronchoscopic pattern recognition: A preliminary study10.1016/j.cmpb.2018.05.016 ↗
6. A machine-learning approach using PET-based radiomics to predict the histological subtypes of lung cancer10.1097/RLU.0000000000002810 ↗
7. Machine-learning-based classification of the histological subtype of non-small-cell lung cancer using MRI texture analysis10.1016/j.bspc.2021.102446 ↗
8. A novel method for lung nodule detection in computed tomography scans based on Boolean equations and vector of filters techniques10.1016/j.compeleceng.2022.107911 ↗
9. Lung nodule malignancy classification in chest computed tomography images using transfer learning and convolutional neural networks10.1007/s00521-018-3895-1 ↗
10. Automated recognition of lung diseases in CT images based on the optimum-path forest classifier10.1007/s00521-017-3048-y ↗
11. Health of things algorithms for malignancy level classification of lung nodules10.1109/ACCESS.2018.2817614 ↗
12. Screening for lung cancer: Who should be screened?10.5858/arpa.2012-0259-RA ↗
13. Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer10.1158/1078-0432.CCR-19-2896 ↗
14. Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non–Small Cell Lung Cancer10.1158/1078-0432.CCR-06-1593 ↗
15. Urinary volatile compounds as biomarkers for lung cancer10.1271/bbb.110760 ↗
16. Urine proteome profiling predicts lung cancer from control cases and other tumors10.1016/j.ebiom.2018.03.009 ↗
17. Research status and funding trends of lung cancer biomarkers
18. Bel’skaya, L.V., Sarf, E.A., Kosenok, V.K., and Gundyrev, I.A. (2020). Biochemical markers of saliva in lung cancer: Diagnostic and prognostic perspectives. Diagnostics, 10.10.3390/diagnostics10040186 ↗
19. Taghizadeh-Hesary, F., Akbari, H., and Bahadori, M. (2022). Anti-mitochondrial therapy: A potential therapeutic approach in oncology. Preprints.10.20944/preprints202201.0171.v2 ↗
20. Digging deeper into volatile organic compounds associated with cancer10.1093/biomethods/bpz014 ↗
21. Multi-centre prospective study on diagnosing subtypes of lung cancer by exhaled-breath analysis10.1016/j.lungcan.2018.09.022 ↗
22. Prediction of lung cancer using volatile biomarkers in breath 110.3233/CBM-2007-3204 ↗
23. Noninvasive detection of lung cancer by analysis of exhaled breath10.1186/1471-2407-9-348 ↗
24. Progress in the development of volatile exhaled breath signatures of lung cancer10.1513/AnnalsATS.201411-540OC ↗
25. Volatile signature for the early diagnosis of lung cancer10.1088/1752-7155/10/1/016007 ↗
26. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease10.1016/j.jtcvs.2014.06.006 ↗
27. Noninvasive detection of lung cancer using exhaled breath10.1002/cam4.162 ↗
28. Breath carbonyl compounds as biomarkers of lung cancer10.1016/j.lungcan.2015.07.005 ↗
29. High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds10.1016/j.jtcvs.2015.08.092 ↗
30. Normalization of exhaled carbonyl compounds after lung cancer resection10.1016/j.athoracsur.2016.04.068 ↗
31. Multimodal chemometric approach for the analysis of human exhaled breath in lung cancer patients by TD-GC× GC-TOFMS10.1016/j.jchromb.2019.01.029 ↗
32. Koureas, M., Kirgou, P., Amoutzias, G., Hadjichristodoulou, C., Gourgoulianis, K., and Tsakalof, A. (2020). Target analysis of volatile organic compounds in exhaled breath for lung cancer discrimination from other pulmonary diseases and healthy persons. Metabolites, 10.10.3390/metabo10080317 ↗
33. Tsou, P.H., Lin, Z.L., Pan, Y.C., Yang, H.C., Chang, C.J., Liang, S.K., Wen, Y.F., Chang, C.H., Chang, L.Y., and Yu, K.L. (2021). Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer. Cancers, 13.10.3390/cancers13061431 ↗
34. Volatile organic compounds of lung cancer and possible biochemical pathways10.1021/cr300174a ↗
35. A review of breath analysis for diagnosis of human health10.1016/j.trac.2011.09.013 ↗
36. Benesty, J., Chen, J., Huang, Y., and Cohen, I. (2009). Pearson correlation coefficient. Noise Reduction in Speech Processing, Springer.10.1007/978-3-642-00296-0_5 ↗
37. Conditional likelihood maximisation: A unifying framework for information theoretic feature selection
38. Deep learning for lung Cancer detection and classification10.1007/s11042-019-08394-3 ↗
39. Gupta, S., and Sedamkar, R. (2020). Machine learning for healthcare: Introduction. Machine Learning with Health Care Perspective, Springer International Publishing.10.1007/978-3-030-40850-3_1 ↗
40. Murray, R.K., Granner, D.K., and Rodwell, V.W. (2006). Harper’s Illustrated Biochemistry, Lange Medical Books. [27th ed.].
41. Breath biomarkers for lung cancer detection and assessment of smoking related effects—Confounding variables, influence of normalization and statistical algorithms10.1016/j.cca.2010.06.005 ↗
42. Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro